Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Nix

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2016
Voriconazole Dosing in Obese PatientsKhalid Eljaaly, David E Nix
The Annals of Pharmacotherapy|May 20, 2022
Considerations When Using Body Mass Index as a Size DescriptorBrian L Erstad, David E Nix
Open Forum Infectious Diseases|June 18, 2024
Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for CoccidioidomycosisJustin F Hayes, David E Nix
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 27, 2023
Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin CBrian L Erstad, David E Nix
The Annals of Pharmacotherapy|November 24, 2020
A Critical Evaluation of Newer β-Lactam Antibiotics for Treatment of <i>Pseudomonas aeruginosa</i> InfectionsKathleen C Blomquist, David E Nix
The Annals of Pharmacotherapy|March 8, 2021
Creatinine Assessment in Non-Steady-State Conditions: A Critical ReviewDavid E Nix, Brian L Erstad
The Journal of Antimicrobial Chemotherapy|April 10, 2010
Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluationDavid E Nix, Kathryn R Matthias
The Annals of Pharmacotherapy|March 9, 2021
Caveats in Kidney Function AssessmentBrian L Erstad, David E Nix
The Annals of Pharmacotherapy|June 23, 2020
Assessment of Kidney Function in Patients With Extreme Obesity: A Narrative ReviewBrian L Erstad, David E Nix
Pharmacotherapy|April 19, 2025
Correction of posaconazole concentrations for hypoalbuminemiaDavid E Nix, Fekade Sime, Jason A Roberts
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2016
Voriconazole Dosing in Obese PatientsKhalid Eljaaly, David E Nix
The Annals of Pharmacotherapy|May 20, 2022
Considerations When Using Body Mass Index as a Size DescriptorBrian L Erstad, David E Nix
Open Forum Infectious Diseases|June 18, 2024
Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for CoccidioidomycosisJustin F Hayes, David E Nix
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 27, 2023
Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin CBrian L Erstad, David E Nix
The Annals of Pharmacotherapy|November 24, 2020
A Critical Evaluation of Newer β-Lactam Antibiotics for Treatment of <i>Pseudomonas aeruginosa</i> InfectionsKathleen C Blomquist, David E Nix
The Annals of Pharmacotherapy|March 8, 2021
Creatinine Assessment in Non-Steady-State Conditions: A Critical ReviewDavid E Nix, Brian L Erstad
The Journal of Antimicrobial Chemotherapy|April 10, 2010
Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluationDavid E Nix, Kathryn R Matthias
The Annals of Pharmacotherapy|March 9, 2021
Caveats in Kidney Function AssessmentBrian L Erstad, David E Nix
The Annals of Pharmacotherapy|June 23, 2020
Assessment of Kidney Function in Patients With Extreme Obesity: A Narrative ReviewBrian L Erstad, David E Nix
Pharmacotherapy|April 19, 2025
Correction of posaconazole concentrations for hypoalbuminemiaDavid E Nix, Fekade Sime, Jason A Roberts
Pageof 7